GB202116745D0 - Prognostic and treatment response predictive method - Google Patents

Prognostic and treatment response predictive method

Info

Publication number
GB202116745D0
GB202116745D0 GBGB2116745.7A GB202116745A GB202116745D0 GB 202116745 D0 GB202116745 D0 GB 202116745D0 GB 202116745 A GB202116745 A GB 202116745A GB 202116745 D0 GB202116745 D0 GB 202116745D0
Authority
GB
United Kingdom
Prior art keywords
prognostic
treatment response
predictive method
response predictive
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2116745.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Cancer Research
Original Assignee
Institute of Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Cancer Research filed Critical Institute of Cancer Research
Priority to GBGB2116745.7A priority Critical patent/GB202116745D0/en
Publication of GB202116745D0 publication Critical patent/GB202116745D0/en
Priority to PCT/EP2022/082510 priority patent/WO2023089146A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB2116745.7A 2021-11-19 2021-11-19 Prognostic and treatment response predictive method Ceased GB202116745D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2116745.7A GB202116745D0 (en) 2021-11-19 2021-11-19 Prognostic and treatment response predictive method
PCT/EP2022/082510 WO2023089146A1 (en) 2021-11-19 2022-11-18 Prognostic and treatment response predictive method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2116745.7A GB202116745D0 (en) 2021-11-19 2021-11-19 Prognostic and treatment response predictive method

Publications (1)

Publication Number Publication Date
GB202116745D0 true GB202116745D0 (en) 2022-01-05

Family

ID=79163981

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2116745.7A Ceased GB202116745D0 (en) 2021-11-19 2021-11-19 Prognostic and treatment response predictive method

Country Status (2)

Country Link
GB (1) GB202116745D0 (en)
WO (1) WO2023089146A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
US7871769B2 (en) * 2004-04-09 2011-01-18 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
WO2012097820A1 (en) * 2011-01-20 2012-07-26 Syddansk Universitet Method and assay for predicting long-term efficacy of tamoxifen treatment in estrogen receptor-positive breast cancer patients
DK3449017T3 (en) * 2016-04-29 2022-03-14 Univ Texas TARGETED MEASUREMENT OF TRANSCRIPTIONAL ACTIVITY REGARDING HORMONE RECEPTORS
KR101874716B1 (en) * 2016-12-14 2018-07-04 연세대학교 산학협력단 Methods for classifyng breast cancer subtypes and a device for classifyng breast cancer subtypes using the same
JOP20210137A1 (en) * 2018-12-06 2023-01-30 Radius Pharmaceuticals Inc Methods for treating cancer resistant to cdk4/6 inhibitors

Also Published As

Publication number Publication date
WO2023089146A1 (en) 2023-05-25

Similar Documents

Publication Publication Date Title
GB201810190D0 (en) Prognostic and treatment response predictive method
SG11202003130TA (en) Prognostic and treatment response predictive method
EP4254419A4 (en) Artificial-intelligence-based cancer diagnosis and cancer type prediction method
GB202006792D0 (en) Method and uses thereof
SG11202008684QA (en) Personal data application and personal data application control method
EP4312179A4 (en) Structure state prediction device, method, and program
GB2574722B (en) Information processing apparatus, control method of information processing apparatus, and program
EP4193236A4 (en) Methods and systems for predictive analysis and/or process control
GB202107699D0 (en) Access control apparatus and method
GB202107266D0 (en) Information processing device information processing method and information processing program
EP4205919A4 (en) Control device and control method
HUP1800091A2 (en) Method and device for proceduring one or more predictors for the prognostic characterization of coronary artery sterosis
GB202116745D0 (en) Prognostic and treatment response predictive method
GB202015200D0 (en) Prognostic and treatment response predictive method
GB202011213D0 (en) Prognostic and treatment response predictive method
GB2611137B (en) Control method and control device
GB202311961D0 (en) Access control method and system
SG11202009944TA (en) Future prediction simulation device, method, and computer program
EP4296014A4 (en) Robot and control method therefor
EP4383494A4 (en) Circuit and control method therefor
EP4194775A4 (en) Refrigerator and operation control method therefor
EP4191482A4 (en) Prediction program, prediction method, and prediction device
EP4319088A4 (en) Access control method and related device
GB2609340B (en) Well access apparatus and method
GB202105040D0 (en) Access control apparatus and method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)